Include Research

 
News Articles for Include Research top ^
2014/1/21
IAMGOLD reports 2013 production and preliminary cash costs; 2014 guidance includes 40% cut in capital spending Canada NewsWire TSX: IMG    NYSE: IAG All amounts are unaudited and expressed in US dollars, unless otherwise indicated.
Sign-up for IAMGOLD reports 2013 production and preliminary cash costs; 2014 guidance includes 40% cut in capital spending investment picks
2013/9/29
Pantelion Films' Instructions Not Included Becomes Highest-Grossing Spanish-Language Film Ever Released in the U.S. Canada NewsWire Film Has Grossed An Estimated $38.6 Million to Date, Becoming Fourth Highest-Grossing Foreign-Language Film of All Time in the U.S. SANTA MONICA, Calif.
Sign-up for Pantelion Films' Instructions Not Included Becomes Highest-Grossing Spanish-Language Film Ever Released in the U.S. investment picks
2013/11/18
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for XELJANZ ® (tofacitinib citrate) to include additional Patient-Reported Outcomes (PRO) data in the label.
Sign-up for Pfizer Announces FDA Approval of Supplemental Application to Expand XELJANZ® (tofacitinib citrate) Labeling to Include Additional Patient-Reported Outcomes Data for Adults with Moderately to Severely Active Rheumatoid Arthritis investment picks
Film Has Grossed An Estimated $38.6 Million to Date, Becoming Fourth Highest-Grossing Foreign-Language Film of All Time in the U.S. SANTA MONICA, Calif.
Sign-up for Pantelion Films' Instructions Not Included Becomes Highest-Grossing Spanish-Language Film Ever Released in the U.S. investment picks
Savvis extends IT infrastructure capabilities to include integrated solutions that power businesses Canada NewsWire Enhanced infrastructure services offer big data, web content, e-commerce and business application capabilities ST.
Sign-up for Savvis extends IT infrastructure capabilities to include integrated solutions that power businesses investment picks
2014/1/29
Derma Sciences, Inc. (the “Company”) (Nasdaq: DSCI), a tissue regeneration company focused on advanced wound care, today announced the closing of an underwritten public offering of 7,500,000 shares of common stock at a price to the public of $11.50 per share, which includes the exercise of the underwriters’ option to purchase 978,261 shares of common stock to cover over-allotments.
Sign-up for Derma Sciences Closes $86 Million Underwritten Public Offering of Common Stock, Including Full Over-Allotment investment picks
2014/2/24
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start (A3921069). “XELJANZ is the first oral JAK inhibitor for moderately to severely active rheumatoid arthritis.
Sign-up for Pfizer Announces FDA Approval to Include Radiographic Data on Reduction of Progression of Structural Joint Damage for Adults with Moderately to Severely Active Rheumatoid Arthritis in Labeling for XELJANZ® (tofacitinib citrate) investment picks
http://media.marketwire.com/attachments/200609/285023_CadenceLOGOcurrent.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1052697&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for Cadence Digital and Custom/Analog Tools Included in TSMC Reference Flows to Enable 16nm FinFET Designs investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0899268001&sourceType=1 http://media3.marketwire.com/docs/GSV_logo_ms_200.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Gold Standard Ventures Intersects 98.1 Meters of 3.26 g/t Gold, Including 17.1 Meters of 9.98 g/t, in the North Bullion Deposit, Railroad Project, Carlin Gold Trend, Nevada investment picks
Easton Pharmaceuticals, Inc. (OTC: EAPH) a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, today announces it has signed a letter of intent to acquire a line of Anti-Ageing and beauty care products.
Sign-up for Easton Pharmaceuticals Signs LOI to Acquire a Cosmetic Anti-Aging and Beauty Care Line of Products Including a Product to Compliment its Medical Marijuana Initiatives investment picks
2013/10/8
Enhanced infrastructure services offer big data, web content, e-commerce and business application capabilities ST.
Sign-up for Savvis extends IT infrastructure capabilities to include integrated solutions that power businesses investment picks
2013/12/12
ACTOR RECOGNITIONS INCLUDE REBECCA FERGUSON, CHIWETEL EJIOFOR, JANET McTEER AND JACQUELINE BISSET BEVERLY HILLS, Calif.
Sign-up for STARZ Receives A Network Record Of Six Golden Globe® Award Nominations Including Two For Best Miniseries investment picks
2013/12/18
CTS Electronic Components, Incorporated (NYSE: CTS), a global leader in designing and manufacturing a diverse array of electronic components for the automotive, communications, medical, industrial, defense and aerospace and computer markets, announces the addition of frequency related Semiconductors to their product offering.
Sign-up for CTS Expands Frequency Portfolio to Include Semiconductors investment picks
Agreements Include Perennial Player Favorite MONOPOLY Brand NEW YORK and PAWTUCKET, R.I. , Jan.
Sign-up for Scientific Games And Hasbro Expand License Deals To Include New Channels, Brands And Territories investment picks
2014/2/28
PLYMOUTH, Mich.
Sign-up for ROFIN Acquires FiLaser's Assets Including Its Unique Laser Cutting Technology investment picks
2014/4/1
Corporate Office Properties Trust (“COPT” or the “Company”) (NYSE: OFC) announced that during the first quarter ended March 31, 2014, the Company completed 176,000 square feet of development leasing at four distinct projects, described below.
Sign-up for COPT Announces 1Q 2014 Development Leasing, Including New Development Start for Cyber Tenant investment picks
Ares Capital Corporation (Nasdaq:ARCC) announced today that it has closed its public offering of 12,650,000 shares of its common stock (including 1,650,000 shares pursuant to the exercise in full by the underwriters of their option to purchase additional shares), raising approximately $214.2 million in net proceeds after deducting underwriting discounts and commissions and estimated offering expenses.
Sign-up for Ares Capital Corporation Closes Public Offering of Common Stock Including Option to Purchase Additional Shares investment picks
2013/10/10
Osiris Therapeutics, Inc. (NASDAQ: OSIR), announced today that it has entered into an agreement with a wholly-owned subsidiary of Mesoblast Limited (ASX:MSB; USOTC:MBLTY) for the sale of Osiris’ culture-expanded mesenchymal stem cell (ceMSC) business, including Prochymal, in a transaction worth up to $100 million in initial consideration and milestone payments.
Sign-up for Osiris Announces Agreement for Culture-Expanded MSCs Including Prochymal Worth Up To $100 Million Plus Royalties investment picks
2013/11/4
Silver Wheaton expands precious metal stream on the Constancia Project to include gold Canada NewsWire TSX: SLW NYSE: SLW VANCOUVER , Nov.
Sign-up for Silver Wheaton expands precious metal stream on the Constancia Project to include gold investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Include Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Include Integration  |  Next: Including Hardware